Furthermore, HDAC inhibitors are often used in the differentiation of HD iPSCs, despite the reported neuroprotective effects of HDAC inhibitors in animal models of HD and human clinical trials [37,41,43,45,157]. The gene discussed is HDAC9; the disease is Huntington disease.